Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Tumor Ablation Therapy Devices Market Size Forecast: How Big Could The Market Get By 2030?
The tumor ablation therapy devices market has seen rapid expansion in recent years. Its value is expected to climb from $0.82 billion in 2025 to $0.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. The historical increase in this market can be attributed to several factors, including a rise in cancer occurrence rates, the establishment of more oncology treatment centers, the growing acceptance of minimally invasive treatments, the availability of advanced imaging technologies, and an increasing preference for organ-preserving therapies.
The tumor ablation therapy devices market size is anticipated to experience substantial growth over the next few years. It is forecast to expand to $1.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This projected increase during the forecast period is due to factors such as increased investments in precision oncology, a rising demand for outpatient cancer treatments, the development of advanced ablation technologies, greater integration of imaging and therapy systems, and a heightened focus on personalized cancer care. Significant trends expected in this period include the growing adoption of minimally invasive tumor ablation procedures, an increase in the use of image-guided ablation systems, a rising need for organ-specific ablation technologies, the expansion of percutaneous treatment approaches, and an intensified focus on precision oncology.
Get A Free Sample Report With In-Depth Market Insights:
Tumor Ablation Therapy Devices Market Demand Drivers Opening New Revenue Streams
The rising incidence of cancer acts as a primary catalyst for the expansion of the tumor ablation therapy devices market. Globally, cancer ranks as the second leading cause of mortality, accounting for approximately 1 in 6 deaths. This growing prevalence of cancer is fueled by aging demographics, given that elderly people face an elevated risk of developing diverse cancer types throughout their lives. Tumor ablation, a minimally invasive technique, is extensively employed for addressing tumors in the lungs, liver, kidneys, and bones. For example, data from the American Cancer Society Inc., a US-based non-profit health organization, projects 1,958,310 new cancer diagnoses in the US in 2023, marking an increase from over 1,918,030 new cases reported in 2022. This procedure serves as an efficacious option for patients unresponsive to chemotherapy or radiotherapy, consequently bolstering the expansion of the tumor ablation therapy devices market.
Tumor Ablation Therapy Devices Market Segment Performance And Emerging Opportunities
The tumor ablation therapy devices market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
Tumor Ablation Therapy Devices Market Trends Powering Strategic Industry Growth
Leading companies in the tumor ablation therapy devices market are prioritizing the development of minimally invasive therapies to secure a competitive advantage. This minimally invasive approach is employed for tumor ablation, delivering precise and effective treatment with minimal disruption to surrounding tissues. For instance, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation is intended to accelerate the device’s development and streamline its regulatory evaluation, potentially leading to faster patient access. Vanquish utilizes the thermal energy present in a small quantity of sterile water to administer accurate treatments to cancerous tissue through a straightforward transurethral procedure. The treatment is engineered to eliminate cancer cells while safeguarding nearby structures, thus decreasing the probability of severe side effects often associated with alternative prostate cancer therapies.
Tumor Ablation Therapy Devices Market Key Participants And Competitive Landscape
Major companies operating in the tumor ablation therapy devices market are Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Bovie Medical Corporation,
View The Full Tumor Ablation Therapy Devices Market Report:
Tumor Ablation Therapy Devices Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the tumor ablation therapy devices market in 2025. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
